【ChiCTR2100047659】THE ROLE OF Ca 19-9, Ca 72-4, CEA AND CHOLESTEROL LEVELS IN PREDICTING MALIGNANCY IN GALLBLADDER POLYPS.
ChiCTR2100047659
结束
/
/
/
2021-06-21
/
/
Gallbladder polyps
THE ROLE OF Ca 19-9, Ca 72-4, CEA AND CHOLESTEROL LEVELS IN PREDICTING MALIGNANCY IN GALLBLADDER POLYPS.
THE ROLE OF Ca 19-9, Ca 72-4, CEA AND CHOLESTEROL LEVELS IN PREDICTING MALIGNANCY IN GALLBLADDER POLYPS.
01000
To determine a new algorithm in the diagnosis and treatment of gallbladder
连续入组
探索性研究/预试验
Ninety patients (MAN/WOMAN) diagnosed with gallbladder polyp by abdominal ultrasonography between December 2017 and November 2020 were included in the study
N/A
Writers
/
11
/
2020-11-18
2020-11-18
/
Ninety patients diagnosed with gallbladder polyp by abdominal ultrasonography between December 2017 and November 2020 were included in the study；
请登录查看Patients who were diagnosed with polyps in an external center, whose cholesterol levels and tumor markers were not tested before the operation, and who had undergone previous interventional procedures to the gallbladder were excluded from the study.；
请登录查看Nazmi OZER
01000
Nazmi OZER的其他临床试验
土耳其Adana city training and research hospital General surgery department的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29